artificially acquired passive immunity
90705 and 90460
The active ingredient is the live, attenuated (weakened) measles virus.
Attenuated whole-agent vaccine
You have live, attenuated viruses in the chicken pox vaccine.
Measles is caused by paramyxo virus and although may have infected humans once to give rise to antigens as immunization can again infect humans.
When vaccinated against measles, a person receives a dose of the measles, mumps, and rubella (MMR) vaccine, which typically contains a weakened form of the measles virus. This live attenuated virus prompts the immune system to recognize and fight against the actual virus if encountered in the future. Additionally, the vaccine may contain stabilizers and preservatives to maintain its effectiveness and safety. The injection stimulates the body to build immunity without causing the disease.
The drug used for the measles vaccine is typically a live attenuated virus called the measles, mumps, and rubella (MMR) vaccine. It helps the immune system develop protective antibodies against the measles virus, preventing infection and providing immunity.
Measles infections appear all over the world. Prior to the current effective immunization program, large-scale measles outbreaks occurred on a two to three-year cycle, usually in the winter and spring.
V06.4 is the ICD9 code for MMR immunzation. MMR stands for measles, mumps, and rubella.
The first measles vaccine was developed by Dr. John Enders and his colleagues in the early 1960s. They successfully cultivated the measles virus in a laboratory, leading to the creation of a live attenuated vaccine. The vaccine was licensed for use in 1963 and has since played a crucial role in reducing measles incidence worldwide.
An attenuated vaccine contains live, weakened microbes. These will multiply at a very low rate in the body but will not cause disease symptoms. This low reproduction rate will allow the body's immune defense to produce an antigen to the pathogen. Because they are live and very close to the natural pathogen, the immunity built from this vaccine generates the strongest immune response.
The vaccine against measles was developed by two scientists named John Enders and Thomas Peebles in 1963. They isolated the measles virus and used it to create a live attenuated vaccine that has since been used globally to prevent measles infections.